Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 mRNA vaccines: intellectual property landscape.

Literature DB >> 32719377

mRNA vaccines: intellectual property landscape.

Cecilia Martin, Drew Lowery.

Abstract

Mesh：

Substances：
RNA, Messenger
Vaccines

Year: 2020 PMID： 32719377 DOI： 10.1038/d41573-020-00119-8

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

Review 1. Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic.

Authors: Chiranjib Chakraborty; Ashish Ranjan Sharma; Manojit Bhattacharya; Garima Sharma; Rudra P Saha; Sang-Soo Lee
Journal: Immune Netw Date: 2021-01-19 Impact factor: 6.303

Review 2. Global landscape of patents related to human coronaviruses.

Authors: Kunmeng Liu; Zixuan Gu; Md Sahidul Islam; Thomas Scherngell; Xiangjun Kong; Jing Zhao; Xin Chen; Yuanjia Hu
Journal: Int J Biol Sci Date: 2021-04-10 Impact factor: 6.580

Review 3. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases.

Authors: Nusrat Zahan Rouf; Sumit Biswas; Nawseen Tarannum; Labiba Mustabina Oishee; Mutia Masuka Muna
Journal: RNA Biol Date: 2021-12-31 Impact factor: 4.652

Review 4. The Delivery of mRNA Vaccines for Therapeutics.

Authors: Jiao Wei; Ai-Min Hui
Journal: Life (Basel) Date: 2022-08-17

5. Patent intelligence of RNA viruses: Implications for combating emerging and re-emerging RNA virus based infectious diseases.

Authors: Pratap Devarapalli; Pragati Kumari; Seema Soni; Vandana Mishra; Saurabh Yadav
Journal: Int J Biol Macromol Date: 2022-09-01 Impact factor: 8.025

mRNA vaccines: intellectual property landscape.

Review 1. Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic.

Review 2. Global landscape of patents related to human coronaviruses.

Review 3. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases.

Review 4. The Delivery of mRNA Vaccines for Therapeutics.

5. Patent intelligence of RNA viruses: Implications for combating emerging and re-emerging RNA virus based infectious diseases.

Review 6. Synthetic modified messenger RNA for therapeutic applications.

Review 7. Increasing efficiency in vaccine Production: A primer for change.

Review 8. COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform.